-
Dr. Chad Lavender performs ACL repair with bone marrow: 3 things to know
Huntington, W. Va.-based Marshall Orthopaedics surgeon Chad Lavender, MD, is now performing anterior cruciate ligament repair procedures using a patient's bone marrow. 7/12/18- -
Stem cell therapy successfully repairs torn meniscus in case study: 4 findings
Adipose-derived autologous stem cell therapy may be used to successfully repair a meniscus injury, according to a study in the Journal of Medical Cases. 7/12/18- -
5 new biologic device launches or releases in 2018
Here are five new biologic device launches or releases in 2018 so far: 7/10/18- -
3 things to know about the NanoFuse Bioactive Matrix
NanoFUSE Biologics will attend the 2018 International Meeting on Advanced Spine Techniques in Los Angeles between July 11 and July 14. 7/9/18- -
SpineMark enters strategic partnership with Regenexx to boost biologic options, patient volume: 4 key points
SpineMark enters strategic partnership with Regenexx to boost biologic options, patient volume: 4 key points 7/5/18- -
NanoFuse Biologics adds orthobiologics executive: 3 insights
NanoFUSE Biologics appointed Archie Yamada as vice president of product business development. 6/28/18- -
Connect Healthcare Collaboration selects Regenexx as solution to lower employers' orthopedic surgery costs
Connect Healthcare Collaboration will recommend Regenexx to its employer partners in order to offer alternatives to orthopedic surgery. 6/27/18- -
Zimmer Biomet to terminate exclusive distribution agreement with BoneSupport: 5 things to know
Zimmer Biomet, the former U.S. exclusive distributor for BoneSupport, cancelled a majority of its Cerament Bone Void Filler orders for a three month period starting in June. 6/25/18- -
Medtronic's Kyphon HV-R Bone Cement receives 2nd indication: 4 key points
Medtronic's Kyphon HV-R Bone Cement receives 2nd indication: 4 key points 6/21/18- -
ACAP Health partners with Regenexx to reduce orthopedic surgery costs — 3 insights
Dallas-based consulting company ACAP Health partnered with interventional orthopedic physician network Regenexx to reduce orthopedic surgery costs for employers. 6/20/18- -
Kuros Biosciences to present case study results of MagnetOs Granules — 3 insights
Kuros Biosciences will present results from clinical case studies of MagnetOs Granules at the 15th annual State of Spine Surgery Think Tank on June 21 to June 23 in Aruba. 6/19/18- -
Dr. Mark McFarland performs spine surgery with SpineFrontier LES Technology & NanoFuse Biologics: 4 highlights
Spine surgeon Mark McFarland, DO, performed a surgery with SpineFrontier's REmind pedicle screw system and LES P-LIFT interbody cages as well as NanoFuse Bioactive Matrix. 6/18/18- -
Wright Medical wins premarket approval for biologic alternative — 6 insights
The FDA granted Wright Medical Group premarket approval for its Augment Injectable Bone Graft. 6/15/18- -
New study will compare Kuros Biosciences' MagnetOs, autograft for spinal fusion: 3 insights
The University Medical Center Utrecht in the Netherlands will begin a study comparing Kuros Biosciences' MagnetOs with autologous bone in posterolateral spinal fusion. 6/14/18- -
Cerapedics earns 2018 MedTech Breakthrough Award for i-FACTOR bone graft— 5 highlights
Cerapedics earned the 2018 MedTech Breakthrough Award for Best New Surgical Technology Solution. 6/13/18- -
Edison Healthcare offers employees biologic-based alternatives to orthopedic surgery: 3 insights
Tulsa, Okla.-based Edison Healthcare partnered with Regenexx to offer its employees alternatives to orthopedic surgery. 6/12/18- -
NuVasive launches AttraX Scaffold biologic: 4 things to know
NuVasive launched the AttraX Scaffold in the U.S. for use in the posterolateral spine to promote fusion. 6/12/18- -
Spine biologics market to grow at CAGR of 4.09% through 2022
The global spine biologics market is expected to grow at a compound annual growth rate of 4.09 percent from 2018 to 2022, according to a 360 Market Updates report. 6/11/18- -
3 things to know about Lattice Biologics
Lattice Biologics is a regenerative medicine company that develops biologic allograft products for bone, skin and cartilage solutions. 6/8/18- -
8 key surgeon Q&As on biologics in orthopedics & spine
Here are eight Q&As on the application of biologics in orthopedics and spine. 6/7/18-
Becker's Healthcare:
- Hospital Review
- ASC Review
- Spine Review
- Clinical
- Health IT & CIO
- CFO
- Dental Review
- 1.800.417.2035
- Email Us
Copyright © 2019 Becker's Healthcare. All Rights Reserved. Interested in linking to or reprinting our content? View our policies by clicking here.